Shift in cytotoxic target from estrogen receptor-positive to estrogen receptor-negative breast cancer cells by trastuzumab in combination with taxane-based chemotherapy.
Shift in cytotoxic target from estrogen receptor-positive to estrogen receptor-negative breast cancer cells by trastuzumab in combination with taxane-based chemotherapy.
复制标题
曲妥珠单抗与紫杉烷类化疗相结合，将细胞毒性靶点从雌激素受体阳性乳腺癌细胞转变为雌激素受体阴性乳腺癌细胞。
作者：
Hayashi M;Kai K;et al.
